Key result
Only 34.6% of surveyed Chinese emergency physicians reported using adenosine for PSVT, and just 58.6% correctly identified the guideline-recommended IV bolus dose.
Why the study?
Adenosine is recommended as first-line therapy for PSVT in international guidelines, but its adoption remains limited in China due to accessibility challenges, cost concerns, and reliance on traditional antiarrhythmics.
Cross-Sectional (n=988)
Yes
A nationwide survey in China reveals significant underutilization of guideline-recommended adenosine for PSVT in emergency departments due to limited accessibility, cost, and knowledge gaps.
Answers are grounded in this paper and cite their sources.
Barriers to adenosine use persist in Chinese EDs; leaves open targeted implementation strategies to improve guideline adherence.
BACKGROUND: Paroxysmal supraventricular tachycardia (PSVT) is a common arrhythmia in emergency departments, with adenosine recommended as the first-line therapy in international guidelines. However, its adoption remains limited in China due to accessibility challenges, cost concerns, and entrenched reliance on traditional antiarrhythmics. AIM: This study aimed to assess the current utilization of adenosine for PSVT in Chinese emergency departments, identify barriers to guideline adherence, and evaluate physicians' knowledge of adenosine administration. METHODS: A cross-sectional survey was conducted among 988 emergency physicians across 10 Chinese provinces from July 1 to July 31, 2024. The questionnaire, distributed via WeChat, collected demographic data, treatment preferences, and knowledge of adenosine's contraindications and side effects. Statistical analysis was performed using GraphPad Prism 9.5.0.730, with chi-square tests for group comparisons. RESULTS: 34.6% of physicians reported adenosine use, contrasting with higher utilization of amiodarone (63.77%) and propafenone (55.77%). Limited accessibility was evident: 53.74% of hospitals stocked adenosine, and only 55.18% of emergency departments maintained consistent supplies. While 58.57% of respondents correctly identified the 6 mg IV bolus dose, knowledge gaps persisted for contraindications and side effects. Attending physicians demonstrated lower protocol adherence than residents and chiefs (P < 0.01). CONCLUSIONS: Emergency physicians, especially those in charge, have a limited understanding of SVT and the appropriate use of adenosine, necessitating further training for this demographic.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2025) conducted a cross-sectional in Paroxysmal supraventricular tachycardia (PSVT) (n=988). Adenosine administration practices and knowledge was evaluated on Reported use of adenosine for PSVT. Only 34.6% of surveyed Chinese emergency physicians reported using adenosine for PSVT, and just 58.6% correctly identified the guideline-recommended IV bolus dose.
Synapse has enriched 10 related papers. Consider them for comparative context: